Browsing Comunicações em Eventos

Factors associated with better overall survival (OS) in patients with previously treated, PD-L1-expressing, advanced NSCLC: Multivariate analysis of KEYNOTE-010.

HERBST, Roy S.; BAAS, Paul; KIM, Dong-Wan; FELIP, Enriqueta; PEREZ-GRACIA, Jose Luis; HAN, Ji-Youn; MOLINA, Julian R.; KIM, Joo-Hang; DUBOS, Catherine; AHN, Arvis Myung-Ju; MAJEM, Margarita; FIDLER, Mary J.; CASTRO, Gilberto; GARRIDO, Marcelo; ELLISON, Misoo C.; SAMKARI, Ayman; LUBINIECKI, Gregory M.; GARON, Edward B. (AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA, USA, 2017)

Feasibility of two schedules of weekly paclitaxel as (neo)adjuvant treatment for patients (PTS) with HER2-negative breast cancer (BC) in the Brazilian community setting

SANTANA, Iuri Amorim; OLIVEIRA, Julia Andrade De; AMARAL, Alan Alves; TESTA, Laura; LANDEIRO, Luciana Garcia; COSTA, Romulo Leopoldo de Paula; HAJIME, Marcelo; FERRARI, Marcela Simonis Martins; PETRY, Vanessa; COHN, Daniela J. B. Heinemann; HOFF, Paulo M.; MANO, Max S. (AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA, USA, 2012)

Febrile neutropenia risk with adjuvant TC (docetaxel and cyclophosphamide) regimen: Experience of Brazilian cancer centers

SANTOS, Joao Paulo Velloso Medrado; GAGLIATO, Debora De Melo; COSSETTI, Rachel Jorge Dino; GIMENEZ, Rodrigo Darouche; MANO, Max S. (AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA, USA, 2014)

Fibrogenesis failure of type V collagen observed in pulmonary and cutaneous fibroblast culture reinforce the pathogenic participation of this collagen in the pathway of systemic sclerosis

TEODORO, W. R.; MORAIS, J.; MARTIN, P.; VELOSA, A. P. P.; CARRASCO, S.; SOUZA, R. B. C.; KATAYAMA, M. L.; GOLDEINSTEIN-SCHAINBERG, C.; PARRA, E. R.; CAPELOZZI, V. L.; YOSHINARI, N. H. (WILEY-BLACKWELL, HOBOKEN, USA, 2012)

Introduction: Unusual type V collagen (COLV) accumulation was demonstrated in systemic sclerosis (SSc) by our group. In this regard, this study analyzed tridimensional reconstruction (3D), biochemical and molecular profile ...

Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1-positive locally advanced/metastatic NSCLC

MOK, T. S. K.; WU, Y-L.; KUDABA, I.; KOWALSKI, D. M.; CHO, B. C.; TURNA, H. Z.; CASTRO JR., G. de; SRIMUNINNIMIT, V.; LAKTIONOV, K. K.; BONDARENKO, I.; KUBOTA, K.; CAGLEVIC, C.; KARASZEWSKA, B.; DANG, T.; YIN, L.; PENROD, J.; LOPES, G. (OXFORD UNIV PRESS, OXFORD, ENGLAND, 2019)

First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK plus ) NSCLC: A Randomized, Phase 3 Study (ASCEND-4)

CASTRO JR., Gilberto De; TAN, Daniel Shao-Weng; CRINO, Lucio; WU, Yi Long; PAZ-ARES, Luis; WOLF, Juergen; GEATER, Sarayut; ORLOV, Sergey; CORTINOVIS, Diego; YU, Chong-Jen; HOCHMAIR, Maximilian; CORTOT, Alexis; TSAI, Chun-Ming; MORO-SIBILOT, Denis; CAMPELO, Rosario Garcia; BRANLE, Fabrice; SEN, Paramita; MCCULLOCH, Tracey; SORIA, Jean-Charles (ELSEVIER SCIENCE INC, NEW YORK, USA, 2017)

first-line cisplatin and irinotecan in advanced or metastatic gastric cancer

CHENG, T. Y.; CORREA, T. Strava; ANDRADE, A. Maria Guimaraes M. C.; MUNIZ, D. Queiroz Borges; MESQUITA, M. Coelho; PEREIRA, G. Luiz Stelko; RIECHELMANN, R. Pimenta; HOFF, P. Marcelo Ghem (ELSEVIER SCI LTD, OXFORD, ENGLAND, 2015)

First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study

MOK, Tony; SCHMID, Peter; CASTRO JR., Gilberto De; SYRIGOS, Kostas; MARTIN, Claudio; YAMAMOTO, Nobuyuki; AREN, Osvaldo; ARRIETA, Oscar; GOTTFRIED, Maya; JAZIEH, Abdul Rahman; RAMLAU, Rodryg; TIMCHEVA, Constanta; TRANI, Leonardo (ELSEVIER SCIENCE INC, NEW YORK, USA, 2017)

FLABRA, FRONTLINE APPROACH FOR BRCA TESTING IN OVARIAN CANCER (OC) TREATMENT NAIVE POPULATION. A LATIN AMERICA (LA) EPIDEMIOLOGIC STUDY

GONCALVES, S.; GIORNELLI, G.; DIZ, M. D. P. Estevez; GALLARDO, D.; KAEN, D. L.; HOYOS, E.; PHILCO, M.; VEGA, M. De la; ABUIN, G. Gomez; JARAMILLO, L. M.; YEPES, A.; LERZO, G.; LIM, M.; JARAMILLO, R. (LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, USA, 2017)

Fraction of diffuse gastric cancer attributable to dietary risk factors.

CORMEDI, Marina Candido Visontai; GUINDALINI, Rodrigo Santa Cruz; BRANAS, Priscila Abduch; ALIZADEH, Behrooz; FOLGUEIRA, Maria A. A. Koike; BOCK, Gertruida H. de (AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA, USA, 2018)

Frequency of CDH1 germline mutations in diffuse gastric cancer in Brazil.

GUINDALINI, Rodrigo Santa Cruz; PASINI, Fatima Solange; GOUVEA, Ana Carolina Ribeiro Chaves De; BRANAS, Priscila Abduch; CORMEDI, Marina Candido Visontai; MAISTRO, Simone; KATAYAMA, Maria Lucia Hirata; ENCINAS, Giselly; NAGY, Tauana; ESTEVEZ-DIZ, Maria Del Pilar; SAFATLE-RIBEIRO, Adriana Vaz; RIBEIRO, Ulysses; FOLGUEIRA, Maria A. A. Koike (AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA, USA, 2015)

Functional characterization of potential new biomarkers in breast cancer

NAGAI, Maria Aparecida (SPANDIDOS PUBL LTD, ATHENS, GREECE, 2013)

Galectin-3 disruption impaired melanoma associated angiogenesis and reduced VEGF secretion from macrophages stimulated by TGF beta 1

MACHADO, Camila; ANDRADE, Luciana Sousa; TEIXEIRA, Veronica; COSTA, Fabricio; MELO, Camila; SANTOS, Sofia dos; NONOGAKI, Suely; LIU, Fu-Tong; BERNARDES, Emerson; CAMARGO, Anamaria; CHAMMAS, Roger (OXFORD UNIV PRESS INC, CARY, USA, 2013)

GD3 ganglioside-enriched extracellular vesicles stimulate melanocyte migration

OTAKE, Andreia H.; DUARTE, Ana Paula M.; SAITO, Renata de Freitas; RAMOS, Alexandre F.; CHAMMAS, Roger (AMER ASSOC CANCER RESEARCH, PHILADELPHIA, USA, 2018)

Gene expression profile of fibroblasts from different topographical origins in breast cancer patients

VALLE, Paulo Roberto Del; KATAYAMA, Maria Lucia Hirata; ROZENCHAN, Patricia Bortman; MILANI, Cintia; LYRA, Eduardo Carneiro; PUGA, Renato; CARRARO, Dirce Maria; BRENTANI, M. Mitzi; FOLGUEIRA, Maria Aparecida Azevedo Koike (AMER ASSOC CANCER RESEARCH, PHILADELPHIA, USA, 2012)

Gene therapy and chemotherapy cooperate to inhibit prostate cancer progression in an animal model

TAMURA, Rodrigo Esaki; STRAUSS, Bryan Eric (AMER ASSOC CANCER RESEARCH, PHILADELPHIA, USA, 2018)

Genetic anticipation in BRCA1/2 families after controlling for ascertainment bias and cohort effect.

GUINDALINI, Rodrigo Santa Cruz; SONG, Andrew; HUO, Dezheng; FACKENTHAL, James; OLOPADE, Olufunmilayo I. (AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA, USA, 2014)

Germline BRCA1 and BRCA2 mutations in Brazilian ovarian and breast cancer patients.

MAISTRO, Simone; ENCINAS, Giselly; NAGY, Tauana; TEIXEIRA, Natalia; KATAYAMA, Maria Lucia H.; GOUVEA, Ana Carolina R. C.; DIZ, Maria del Pilar E.; CHAMMAS, Roger; BOCH, Geertruida H. de; FOLGUEIRA, Maria Aparecida A. K. (AMER ASSOC CANCER RESEARCH, PHILADELPHIA, USA, 2018)

GLOBAL LONGITUDINAL ASSESSMENT OF TREATMENT OUTCOMES IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (GLANCE-H&N) STUDY

GRUENWALD, V; CHIROVSKY, D.; CHEUNG, W.; BERTOLINI, F.; AHN, M.; YANG, M.; CASTRO, Jr G. de; BERROCAL, A.; SJOQUIST, K.; KUYAS, H.; AUCLAIR, V; GUILLAUME, X.; SHAH, R.; HARRINGTON, K. (ELSEVIER SCIENCE INC, NEW YORK, USA, 2018)

Global, Phase 3 study of first-line durvalumab (MEDI4736) + tremelimumab vs standard of care platinum-based chemotherapy in advanced/metastatic NSCLC: NEPTUNE

MOK, T.; SCHMID, P.; CASTRO JR., G. de; SYRIGOS, K.; MARTIN, C.; YAMAMOTO, N.; AREN, O.; ARRIETA, O.; GOTTFRIED, M.; JAZIEH, A. R.; RAMLAU, R.; TIMCHEVA, C.; TRANI, L. (OXFORD UNIV PRESS, OXFORD, ENGLAND, 2016)

Browsing Comunicações em Eventos - LIM/24 by Title

Browsing Comunicações em Eventos - LIM/24 by Title

Search DSpace

Browse

All of DSpace

This Collection

My Account